PATENT CLAIM ANALYSIS

Application Number: 16124026
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["702", "019000"]

Abstract:
A method of administering insulin includes receiving subcutaneous information for a patient at a computing device and executing a subcutaneous outpatient program for determining recommended insulin dosages. The subcutaneous outpatient program includes obtaining blood glucose data of the patient from a glucometer in communication with the computing device, aggregating blood glucose measurements to determine a representative aggregate blood glucose measurement associated with at least one scheduled blood glucose time interval, and determining a next recommended insulin dosage for the patient based on the representative aggregate blood glucose measurement and the subcutaneous information. The method also includes transmitting the next recommended insulin dosage to a portable device associated with the patient. The portable device displays the next recommended insulin dosage.

Claim (Index 7):
The method of  claim 1 , wherein the administration device comprises a smart insulin pen.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 97.0
- Lexical Diversity: 2.23214
- Patent Class: 702.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15855315', '14922763', '15342606', '15942740', '14938997']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.4030579881649047
- 35 USC 102 Novelty (BERT): 0.6126365397012152
- Combined Prediction Score: 0.4240158433185357
- Mean Citation Score: 690.325874
- Max Citation Score: 786.6817599999997
- Similarity Product: 477.2999420292472

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test